Weekly Recap | AEON Biopharma, Inc. +5.84%, spiking then fading after ABP-450 updateWeekly Review·Oct 3, 2026 at 06:14 AMAEON+1.42%
Weekly Recap | AEON Biopharma, Inc. -25.82%, consensus target sits above spotWeekly Review·Sep 19, 2026 at 05:34 AMAEON+1.42%
Weekly Recap | AEON Biopharma, Inc. +35.76%, migraine candidate news drives volume surgeWeekly Review·Sep 12, 2026 at 05:54 AMAEON+1.42%
